Neuphoria Therapeutics Statistics

Total Valuation

NEUP has a market cap or net worth of $24.70 million. The enterprise value is $5.29 million.

Market Cap	24.70M
Enterprise Value	5.29M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

NEUP has 5.40 million shares outstanding. The number of shares has increased by 161.08% in one year.

Current Share Class	5.40M
Shares Outstanding	5.40M
Shares Change (YoY)	+161.08%
Shares Change (QoQ)	+19.29%
Owned by Insiders (%)	3.41%
Owned by Institutions (%)	36.13%
Float	4.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-1,861.67
Forward PS	n/a
PB Ratio	0.84
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.31, with a Debt / Equity ratio of 0.00.

Current Ratio	14.31
Quick Ratio	13.91
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.90% and return on invested capital (ROIC) is -166.79%.

Return on Equity (ROE)	-62.90%
Return on Assets (ROA)	-27.97%
Return on Invested Capital (ROIC)	-166.79%
Return on Capital Employed (ROCE)	-44.03%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$2.18M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-370,982
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.71%
50-Day Moving Average	4.89
200-Day Moving Average	5.90
Relative Strength Index (RSI)	48.11
Average Volume (20 Days)	71,615

Short Selling Information

The latest short interest is 23,029, so 0.43% of the outstanding shares have been sold short.

Short Interest	23,029
Short Previous Month	36,835
Short % of Shares Out	0.43%
Short % of Float	0.55%
Short Ratio (days to cover)	0.32

Income Statement

In the last 12 months, NEUP had revenue of -$13,267 and -$17.43 million in losses. Loss per share was -$4.95.

Revenue	-13,267
Gross Profit	-13,267
Operating Income	-14.66M
Pretax Income	-17.80M
Net Income	-17.43M
EBITDA	-14.00M
EBIT	-14.66M
Loss Per Share	-$4.95

Full Income Statement

Balance Sheet

The company has $19.44 million in cash and $34,225 in debt, giving a net cash position of $19.41 million or $3.59 per share.

Cash & Cash Equivalents	19.44M
Total Debt	34,225
Net Cash	19.41M
Net Cash Per Share	$3.59
Equity (Book Value)	29.42M
Book Value Per Share	5.47
Working Capital	20.14M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.15M
Capital Expenditures	n/a
Depreciation & Amortization	662,901
Net Borrowing	n/a
Free Cash Flow	-17.15M
FCF Per Share	-$3.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	110,513.32%
Pretax Margin	134,183.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NEUP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-161.08%
Shareholder Yield	-161.08%
Earnings Yield	-70.57%
FCF Yield	-69.44%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NEUP has an Altman Z-Score of -6.15 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.15
Piotroski F-Score	2